Phase 3 Clinical Trials

Concizumab Phase 3 Results Expected

Ianalumab Phase 3 Results Expected

Cisplatin + Gemcitabine Phase 3 Results Expected

Centanafadine Hydrochloride Phase 3 Results Expected

Remibrutinib Phase 3 Results Expected

Cyclophosphamide Phase 3 Results Expected

Tremelimumab Phase 3 Results Expected

Vincristine Phase 3 Results Expected

IVA Phase 3 Results Expected

Prednisone Phase 3 Results Expected

Polatuzumab Vedotin Phase 3 Results Expected

PTC923 Phase 3 Results Expected

Rituximab Phase 3 Results Expected

Enfortumab Vedotin Phase 3 Results Expected

BNT162b2 (2025/2026 recommended SARS-CoV-2 strain) Phase 3 Results Expected

Sibeprenlimab 400 mg Phase 3 Results Expected

Sinovac PCV13 Phase 3 Results Expected

Eplontersen Phase 3 Results Expected

Ramucirumab+ paclitaxel Phase 3 Results Expected

AZD0901 Phase 3 Results Expected

Remimazolam Tosilate for injection Phase 3 Results Expected

Ubrogepant Phase 3 Results Expected

NMRA-335140 Phase 3 Results Expected

XL092 Phase 3 Results Expected

Xembify Phase 3 Results Expected

BHV-7000 Phase 3 Results Expected

Lumateperone Phase 3 Results Expected

MM120 (LSD D-Tartrate) Phase 3 Results Expected

Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected

Venglustat (GZ402671) Phase 3 Results Expected

Regorafenib Phase 3 Results Expected

Plozasiran Injection Phase 3 Results Expected

Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected

ELIXCYTE Phase 3 Results Expected

SHR2554; Chidamide analog tablets Phase 3 Results Expected

Efanesoctocog alfa Phase 3 Results Expected

Topical corticosteroids Phase 3 Results Expected

Amlitelimab Phase 3 Results Expected

Topical tacrolimus or pimecrolimus Phase 3 Results Expected

Bimekizumab Phase 3 Results Expected

RSVt Vaccine Phase 3 Results Expected

Placebo Phase 3 Results Expected

Durvalumab Phase 3 Results Expected

Ribociclib Phase 3 Results Expected

Alectinib Phase 3 Results Expected

Tradipitant Phase 3 Results Expected

Rituximab Phase 3 Results Expected

Lenalidomide Phase 3 Results Expected

Mosunetuzumab Phase 3 Results Expected

Tociluzumab Phase 3 Results Expected

Fp/ABS Phase 3 Results Expected

Short regimen of benznidazole Phase 3 Results Expected

Tenapanor 50 MG Phase 3 Results Expected

Centanafadine Phase 3 Results Expected

HS-20117 Phase 3 Results Expected

SHR7280 tablets Phase 3 Results Expected

Durvalumab Phase 3 Results Expected

cisplatin + fluorouracil Phase 3 Results Expected

Tirzepatide Phase 3 Results Expected

Cagrilintide Phase 3 Results Expected

Semaglutide Phase 3 Results Expected

zilucoplan (RA101495) Phase 3 Results Expected

Botulinum toxin type A Phase 3 Results Expected

MenACYW135 polysaccharide vaccine Phase 3 Results Expected

Zasocitinib Phase 3 Results Expected

MenACYW conjugate vaccine Phase 3 Results Expected

Dupilumab Phase 3 Results Expected

rozanolixizumab Phase 3 Results Expected

Seladelpar 10 mg Phase 3 Results Expected

Cretostimogene Grenadenorepvec Phase 3 Results Expected

Miglustat Phase 3 Results Expected

Tasimelteon Phase 3 Results Expected

1mg elsunersen Phase 3 Results Expected

nab-paclitaxel Phase 3 Results Expected

Domvanalimab Phase 3 Results Expected

Vadadustat Phase 3 Results Expected

olvimulogene nanivacirepvec Phase 3 Results Expected

Zimberelimab Phase 3 Results Expected

Plozasiran Injection Phase 3 Results Expected

Aficamten Phase 3 Results Expected

68Ga-PSMA-11 Phase 3 Results Expected